The H19 gene is the basis of BioCancell's first patient-oriented, personalized cancer therapies. H19 plays a significant role in the…
Targeted therapy that attacks cancerous cells without harming healthy tissue. Impressive safety profile.
Clinical trials being conducted wordwide in various types of cancer.
10 patent families. Lead compound patents granted worldwide. Patents for diagnostics and therapeutics.
